SELECT MEDICAL HOLDINGS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.5B | $5.2B | $4.8B | $4.6B | $6.2B |
| Operating income | $336.2M | $268.3M | $267.2M | $144.8M | $713.8M |
| Interest expense | $117.9M | $128.6M | $198.6M | $169.1M | $136.0M |
| Pretax income | $272.7M | $174.8M | $139.7M | $35.3M | $629.7M |
| Income tax expense | $58.2M | $44.8M | $29.3M | $16.7M | $129.8M |
| Net income | $146.2M | $214.0M | $243.5M | $159.0M | $402.2M |
| Balance Sheet | |||||
| Cash and equivalents | $26.5M | $59.7M | $52.6M | $97.9M | $74.3M |
| Current assets | $1.0B | $1.0B | $1.3B | $1.3B | $1.1B |
| Total assets | $5.9B | $5.6B | $7.7B | $7.7B | $7.4B |
| Current liabilities | $984.5M | $977.7M | $1.2B | $1.2B | $1.3B |
| Total liabilities | $3.8B | $3.6B | $6.1B | $6.3B | $6.0B |
| Stockholders' equity | $1.7B | $1.7B | $1.3B | $1.1B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | $346.5M | $517.9M | $582.1M | $284.8M | $401.2M |
| Depreciation and amortization | $138.5M | $141.1M | $134.1M | $130.3M | $173.2M |
| Stock-based compensation | $16.7M | $100.7M | $43.8M | $37.8M | $30.9M |
| Capital expenditure | $229.2M | $222.2M | $229.2M | $190.4M | $180.5M |
| Free cash flow | $117.2M | $295.7M | $352.9M | $94.5M | $220.7M |
| Dividends paid | $31.4M | $64.6M | $63.9M | $64.6M | $50.6M |
| Share repurchases | $100.1M | $37.9M | $12.8M | $195.5M | $79.5M |
Shares outstanding 124.0M · Free float 84.0%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.